Dronedarone and Captisol-enabled amiodarone in an experimental cardiac arrest.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY(2013)

Cited 4|Views3
No score
Abstract
Objective: To compare the energy required for defibrillation and postshock outcomes after the administration of dronedarone, amiodarone, and placebo in a porcine model of cardiac arrest. Methods: Forty-two pigs were randomized to amiodarone, dronedarone, or control treatments. After induction of ventricular fibrillation, compressions and ventilations were performed for 3 minutes and treatment was administered over 30 seconds. If defibrillation was unsuccessful, cardiopulmonary resuscitation continued and repeated shocks were administered every 2 minutes with continual hemodynamic monitoring for a total duration of 30 minutes. Results: The cumulative energy required for defibrillation was 570 +/- 422 J for dronedarone, 441 +/- 365 J for amiodarone, and 347 +/- 281 J for control (P = not significant). Survival at 30 minutes was 1 (7.1%) for dronedarone compared with 11 (78.6%) for control (P = 0.001). Mortality in the dronedarone group was because of refibrillation in 3 (21.4%) cases, atrioventricular block in 1 (7.1%) case, and hypotension not because of bradycardia in 9 (64.3%) cases. Two minutes after successful defibrillation, systolic aortic pressure was lower in dronedarone versus control (86.6 +/- 26.9 vs. 110 +/- 15.1 mm Hg; P = 0.035). Conclusions: The administration of dronedarone resulted in a significant reduction in survival and both systolic aortic and coronary perfusion pressure compared with control.
More
Translated text
Key words
dronedarone,nexterone,cardiac arrest,drug therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined